Results 11 to 20 of about 8,627 (128)
RET Proto-oncogene C634Y Mutation-associated Multiple Endocrine Adenomatosis Type 2A: a Case Report and Literature Review [PDF]
Zhongguo quanke yixue, 2023 Multiple endocrine adenomatosis type 2A (MEN2A) is a subtype of multiple endocrine adenomatosis type 2, which is clinically characterized by medulloid thyroid carcinoma (MTC) , pheochromocytoma (PHEO) , and hyperparathyroidism, and has been reported to ...
DENG Yuxuan, HE Li, SONG Zhiwang, JIANG Yanxia
doaj +1 more source
Surgical treatment of a patient with multiple endocrine neoplasia type 2A
Вестник хирургии имени И.И. Грекова, 2020 The diagnosis and treatment of multiple endocrine neoplasia type 2A syndrome or Sipple’s syndrome, as well as other endocrine hereditary syndromes, presents certain difficulties for several reasons.
T. A. Britvin +7 more
doaj +1 more source
Over-representation of the G12S polymorphism of the SDHD gene in patients with MEN2A syndrome
Clinics, 2012 OBJECTIVE: To evaluate whether germline variants of the succinate dehydrogenase genes might be phenotypic modifiers in patients with multiple endocrine neoplasia type 2.
Nikoletta Lendvai +10 more
doaj +1 more source
Multiple endocrine neoplasia type 2A (Sipple syndrome)
Acta Medica Leopoliensia, 2017 Aim. To improve diagnosis and differential diagnosis of diseases with hypertension, including multiple endocrine meoplasia, their timely diagnosis and appropriate treatment of patients. Material and Methods.
O.V. Safonova +2 more
doaj +1 more source
Journal of Medical Case Reports, 2017 Background Composite pheochromocytoma/paragangliomas are very rare tumors composed of ordinary pheochromocytoma paragangliomas associated with neurogenic tumors. Several hereditary susceptibility disorders are known to be associated with pheochromocytoma/
Boubacar Efared +6 more
doaj +1 more source
Genotype-phenotype correlation in multiple endocrine neoplasia type 2
Clinics, 2012 Multiple endocrine neoplasia type 2 is an autosomal-dominant hereditary cancer syndrome caused by missense gain-of-function mutations of the rearranged during transfection proto-oncogene, which encodes the receptor tyrosine kinase, on chromosome 10.
Friedhelm Raue, Karin Frank-Raue
doaj +1 more source
A novel mutation identified in a patient with pheochromocytoma and renal cell carcinoma [PDF]
Kosin Medical Journal, 2018 Pheochromocytomas might be sporadic or genetic. Genetic pheochromocytoma is associated with multiple endocrine neoplasia (MEN) type 2A, MEN type 2B, and von Hippel-Lindau (VHL) disease. RET mutations are identified in more than 90% of index cases of MEN2
Jae Wan Kwon +5 more
doaj +1 more source
Syncronous medullar thyroid cancer and primary hyperparathyroidism on a female within the sixth decade of life with positive family history for type 2A MEN syndrome [PDF]
Romanian Journal of Medical Practice, 2016 Medullar thyroid cancer (MTC) may be sporadic or familial, either linked with pheocromocytoma (PHEO) and primary hyperparathyrodism (PHP), as seen in type 2A MEN (Multiple Endocrine Neoplasia) syndrome, either isolated.
Ana VALEA +4 more
doaj +1 more source
Journal of the Formosan Medical Association, 2009 Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant cancer predisposition syndrome, and > 95% of MEN 2 patients carry rearranged during transfection (RET) protooncogene mutants.
Chin-Feng Chang +4 more
doaj +1 more source
From Childhood Migraine Headache to Pheochromocytoma
Case Reports in Endocrinology, 2014 Pheochromocytoma may have multiple clinical manifestations including paroxysmal hypertension, tachycardia, sweating, nausea, and headache (Phillips et al., 2002). Migraine has some of the manifestations seen with pheochromocytoma.
Y. M. Hazimeh +3 more
doaj +1 more source